# Oxaliplatin and 5-FU Based Preoperative Chemoradiation

> **NCT00278694** · PHASE2 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 109 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** Chemoradiation
- **DRUG:** 5-FU
- **RADIATION:** Preoperative chemoradiation
- **PROCEDURE:** Pelvic surgery
- **DRUG:** Neoadjuvant oxaliplatin

## Key facts

- **NCT ID:** NCT00278694
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2016-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00278694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00278694, "Oxaliplatin and 5-FU Based Preoperative Chemoradiation". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00278694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*